BKV Corporation (NYSE:BKV - Get Free Report) has been assigned an average recommendation of "Buy" from the eight ratings firms that are covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $28.13.
A number of analysts recently issued reports on BKV shares. Barclays boosted their price objective on BKV from $28.00 to $29.00 and gave the company an "overweight" rating in a research note on Monday, May 12th. Evercore ISI upped their price target on BKV from $20.00 to $26.00 and gave the company an "outperform" rating in a research report on Friday, May 30th. Truist Financial cut their price objective on shares of BKV from $31.00 to $30.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Finally, KeyCorp reduced their price objective on shares of BKV from $27.00 to $25.00 and set an "overweight" rating for the company in a research note on Tuesday, March 4th.
Get Our Latest Research Report on BKV
BKV Stock Down 2.1%
Shares of BKV stock traded down $0.48 on Tuesday, hitting $21.97. 218,380 shares of the stock were exchanged, compared to its average volume of 433,042. The firm's 50 day moving average is $19.45 and its two-hundred day moving average is $21.47. BKV has a one year low of $15.00 and a one year high of $26.78.
BKV (NYSE:BKV - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.26. The business had revenue of $216.13 million during the quarter, compared to the consensus estimate of $223.20 million. As a group, equities research analysts predict that BKV will post -1.82 earnings per share for the current year.
Insider Buying and Selling
In other BKV news, insider Ethan Ngo sold 21,667 shares of the stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $20.09, for a total transaction of $435,290.03. Following the transaction, the insider now directly owns 286,008 shares in the company, valued at $5,745,900.72. This trade represents a 7.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David Tameron sold 4,409 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $17.94, for a total transaction of $79,097.46. Following the completion of the sale, the chief financial officer now directly owns 43,370 shares of the company's stock, valued at $778,057.80. This represents a 9.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 183,777 shares of company stock worth $3,818,699. Insiders own 4.11% of the company's stock.
Institutional Trading of BKV
Several hedge funds and other institutional investors have recently bought and sold shares of BKV. Driehaus Capital Management LLC purchased a new stake in BKV during the 4th quarter valued at $9,553,000. Geode Capital Management LLC bought a new position in BKV during the 4th quarter valued at approximately $7,728,000. Quantbot Technologies LP purchased a new stake in BKV in the first quarter worth $1,605,000. Bank of New York Mellon Corp purchased a new position in shares of BKV during the fourth quarter valued at about $695,000. Finally, Corebridge Financial Inc. bought a new position in shares of BKV in the 4th quarter worth approximately $170,000.
BKV Company Profile
(
Get Free ReportBKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
See Also

Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.